DaVita Graham Number from 2010 to 2024

DVA Stock  USD 166.99  1.48  0.89%   
DaVita HealthCare's Graham Number is increasing over the years with slightly volatile fluctuation. Overall, Graham Number is expected to go to 46.88 this year. From 2010 to 2024 DaVita HealthCare Graham Number quarterly data regression line had arithmetic mean of  37.15 and r-squared of  0.39. View All Fundamentals
 
Graham Number  
First Reported
2010-12-31
Previous Quarter
44.64905076
Current Value
46.88
Quarterly Volatility
12.15571632
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check DaVita HealthCare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among DaVita HealthCare's main balance sheet or income statement drivers, such as Depreciation And Amortization of 782.7 M, Interest Expense of 273.6 M or Total Revenue of 7.1 B, as well as many indicators such as Price To Sales Ratio of 0.74, Dividend Yield of 0.0129 or PTB Ratio of 9.46. DaVita financial statements analysis is a perfect complement when working with DaVita HealthCare Valuation or Volatility modules.
  
Check out the analysis of DaVita HealthCare Correlation against competitors.

Latest DaVita HealthCare's Graham Number Growth Pattern

Below is the plot of the Graham Number of DaVita HealthCare Partners over the last few years. It is DaVita HealthCare's Graham Number historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in DaVita HealthCare's overall financial position and show how it may be relating to other accounts over time.
Graham Number10 Years Trend
Slightly volatile
   Graham Number   
       Timeline  

DaVita Graham Number Regression Statistics

Arithmetic Mean37.15
Geometric Mean30.58
Coefficient Of Variation32.72
Mean Deviation8.20
Median40.73
Standard Deviation12.16
Sample Variance147.76
Range46.5719
R-Value0.63
Mean Square Error96.57
R-Squared0.39
Significance0.01
Slope1.70
Total Sum of Squares2,069

DaVita Graham Number History

2024 46.88
2023 44.65
2022 37.73
2021 38.76
2020 40.97
2019 40.73
2018 47.51

About DaVita HealthCare Financial Statements

DaVita HealthCare stakeholders use historical fundamental indicators, such as DaVita HealthCare's Graham Number, to determine how well the company is positioned to perform in the future. Although DaVita HealthCare investors may analyze each financial statement separately, they are all interrelated. For example, changes in DaVita HealthCare's assets and liabilities are reflected in the revenues and expenses on DaVita HealthCare's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in DaVita HealthCare Partners. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Graham Number 44.65  46.88 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether DaVita HealthCare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of DaVita HealthCare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Davita Healthcare Partners Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Davita Healthcare Partners Stock:
Check out the analysis of DaVita HealthCare Correlation against competitors.
You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DaVita HealthCare. If investors know DaVita will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DaVita HealthCare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.05)
Earnings Share
9.29
Revenue Per Share
145.293
Quarterly Revenue Growth
0.046
Return On Assets
0.0694
The market value of DaVita HealthCare is measured differently than its book value, which is the value of DaVita that is recorded on the company's balance sheet. Investors also form their own opinion of DaVita HealthCare's value that differs from its market value or its book value, called intrinsic value, which is DaVita HealthCare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DaVita HealthCare's market value can be influenced by many factors that don't directly affect DaVita HealthCare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DaVita HealthCare's value and its price as these two are different measures arrived at by different means. Investors typically determine if DaVita HealthCare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DaVita HealthCare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.